Shireesh Saurabh1, Yubo Gao2, Sara Maduka3, Lori Smith3, Rachel Lasley3, Namrata Singh2. 1. General / Bariatric Surgery, Mercy Hospital, 540 East-Jefferson Street, Suite 205, Iowa City, IA, 52245, USA. shireesh22@gmail.com. 2. University of Iowa Hospital and Clinics, Iowa City, IA, 52242, USA. 3. Mercy Hospital, Iowa City, IA, 52245, USA.
Abstract
BACKGROUND: Laparoscopic Roux-en-Y gastric bypass (LRYGB) patients are recommended to take multiple oral vitamin supplements daily. Transdermal multivitamin patches are being advertised as an alternative for use in bariatric patients with no data to support their efficacy. The purpose of this study was to evaluate response to daily transdermal use of multivitamin patch after LRYGB and to compare them with a control group of similar patients who used oral supplements. METHODS: A retrospective review was carried out on patients who had LRYGB at a community hospital from February 2015 to February 2019. Patients who had completed preoperative and annual postoperative bariatric laboratory tests were included. They were divided into patch and pill (control) group. RESULTS: Seventeen patients were included in the patch and 27 in the pill group. Patients in each group used either patch or pills for 12 months and they were 1 year post LRYGB. Fourteen patients (82.35%) in patch group and 11 patients (40.74%) in pill group had at least 1 deficiency at annual postoperative blood work (P = .0116). Vitamin D deficiency was seen in 81% patients in patch group vs 36% in the pill group (P = .0092). Statistically significant lower postoperative serum concentrations of vitamin D, B1, and B12 were seen in the patch group. CONCLUSIONS: Multivitamin patch users are more likely to have vitamin D deficiency and lower serum concentration of various vitamins and minerals. Future large studies are needed on the efficacy of multivitamin patches before they can be recommended to bariatric patient population.
BACKGROUND: Laparoscopic Roux-en-Y gastric bypass (LRYGB) patients are recommended to take multiple oral vitamin supplements daily. Transdermal multivitamin patches are being advertised as an alternative for use in bariatric patients with no data to support their efficacy. The purpose of this study was to evaluate response to daily transdermal use of multivitamin patch after LRYGB and to compare them with a control group of similar patients who used oral supplements. METHODS: A retrospective review was carried out on patients who had LRYGB at a community hospital from February 2015 to February 2019. Patients who had completed preoperative and annual postoperative bariatric laboratory tests were included. They were divided into patch and pill (control) group. RESULTS: Seventeen patients were included in the patch and 27 in the pill group. Patients in each group used either patch or pills for 12 months and they were 1 year post LRYGB. Fourteen patients (82.35%) in patch group and 11 patients (40.74%) in pill group had at least 1 deficiency at annual postoperative blood work (P = .0116). Vitamin D deficiency was seen in 81% patients in patch group vs 36% in the pill group (P = .0092). Statistically significant lower postoperative serum concentrations of vitamin D, B1, and B12 were seen in the patch group. CONCLUSIONS: Multivitamin patch users are more likely to have vitamin D deficiency and lower serum concentration of various vitamins and minerals. Future large studies are needed on the efficacy of multivitamin patches before they can be recommended to bariatric patient population.
Authors: Juan Ybarra; Joan Sánchez-Hernández; Ignasi Gich; Alberto De Leiva; Xavier Rius; Jose Rodríguez-Espinosa; Antonio Pérez Journal: Obes Surg Date: 2005-03 Impact factor: 4.129
Authors: Arthur M Carlin; D Sudhaker Rao; Ali M Meslemani; Jeffrey A Genaw; Nayana J Parikh; Shiri Levy; Arti Bhan; Gary B Talpos Journal: Surg Obes Relat Dis Date: 2006-02-28 Impact factor: 4.734
Authors: Wendy Schijns; Lisanne T Schuurman; Alida Melse-Boonstra; Cees J H M van Laarhoven; Frits J Berends; Edo O Aarts Journal: Surg Obes Relat Dis Date: 2018-04-03 Impact factor: 4.734
Authors: Manuel Ruz; Fernando Carrasco; Pamela Rojas; Juana Codoceo; Jorge Inostroza; Annabella Rebolledo; Karen Basfi-fer; Attila Csendes; Karin Papapietro; Fernando Pizarro; Manuel Olivares; Lei Sian; Jamie L Westcott; K Michael Hambidge; Nancy F Krebs Journal: Am J Clin Nutr Date: 2009-07-22 Impact factor: 7.045
Authors: Jens Homan; Wendy Schijns; Edo O Aarts; Cees J H M van Laarhoven; Ignace M C Janssen; Frits J Berends Journal: Surg Obes Relat Dis Date: 2015-12-10 Impact factor: 4.734
Authors: Geoffrey Roberts; Patrick R Benusiglio; Tanya Bisseling; Daniel Coit; Jeremy L Davis; Sam Grimes; Theresa A Guise; Richard Hardwick; Kirsty Harris; Paul Furman Mansfield; Jeremy Rossaak; Karen Chelcun Schreiber; Peter P Stanich; Vivian E Strong; Pardeep Kaurah Journal: Gastric Cancer Date: 2022-07-13 Impact factor: 7.701
Authors: Maria G Grammatikopoulou; Konstantinos Gkiouras; Efthimios Dardiotis; Efterpi Zafiriou; Christina Tsigalou; Dimitrios P Bogdanos Journal: Metabol Open Date: 2021-07-13